Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-inflammatory agent 86 is a derivative of Chrysin with anti-inflammatory properties. It inhibits TNF-α-induced monocyte adhesion to colon epithelium, with an IC50 of 4.71 μM. Anti-inflammatory agent 86 shows potential for use in inflammatory bowel disease (IBD) research.

| Description | Anti-inflammatory agent 86 is a derivative of Chrysin with anti-inflammatory properties. It inhibits TNF-α-induced monocyte adhesion to colon epithelium, with an IC50 of 4.71 μM. Anti-inflammatory agent 86 shows potential for use in inflammatory bowel disease (IBD) research. |
| In vitro | Anti-inflammatory agent 86 (Compound 4b) significantly inhibits TNF-α-induced monocyte adhesion to HT-29 cells, with an IC₅₀ of 4.71 μM. At concentrations of 5-10 μM over 4 hours, it markedly suppresses MCP-1 expression in a concentration-dependent manner. Additionally, Anti-inflammatory agent 86 inhibits NF-κB activity and TNF-α-induced ROS production in a dose-dependent manner in HT-29 cells. |
| In vivo | The compound, referred to as Anti-inflammatory agent 86 (30-60 mg/kg; oral administration; once daily; for 15 consecutive days), demonstrates the most significant efficacy in treating TNBS-induced colitis. |
| Formula | C29H34N2O5S2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.